Skip to content
10-Q

Quarterly Report

Aevi Genomic Medicine, Inc.

0001104659-19-063708

← back to feed
Filed
Nov 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 11, 2019 64.77M sh
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$11.7M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$19.12M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $2.38M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $12.08M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $19.6M
Cash And Equivalents Q3 2019 · Dec 31, 2017 $33.73M
Stockholders Equity Q3 2019 · Sep 30, 2019 −$3.46M
Stockholders Equity Q3 2019 · Jun 30, 2019 $332K
Stockholders Equity Q3 2019 · Dec 31, 2018 $7.93M
Stockholders Equity Q3 2019 · Sep 30, 2018 $13.75M
Stockholders Equity Q3 2019 · Jun 30, 2018 $15.29M
Stockholders Equity Q3 2019 · Dec 31, 2017 $30.62M
Current Liabilities Q3 2019 · Sep 30, 2019 $4.25M
Current Liabilities Q3 2019 · Dec 31, 2018 $4.35M
Total Liabilities Q3 2019 · Sep 30, 2019 $6.25M
Total Liabilities Q3 2019 · Dec 31, 2018 $4.35M
Current Assets Q3 2019 · Sep 30, 2019 $2.78M
Current Assets Q3 2019 · Dec 31, 2018 $12.25M
Total Assets Q3 2019 · Sep 30, 2019 $2.8M
Total Assets Q3 2019 · Dec 31, 2018 $12.28M
Sga Expense Q3 2019 · Sep 30, 2019 $1.54M
Sga Expense Q3 2019 · Sep 30, 2019 $4.64M
Sga Expense Q3 2019 · Sep 30, 2018 $2.17M
Sga Expense Q3 2019 · Sep 30, 2018 $6.85M
Rd Expense Q3 2019 · Sep 30, 2019 $2.5M
Rd Expense Q3 2019 · Sep 30, 2019 $7.9M
Rd Expense Q3 2019 · Sep 30, 2018 $5.13M
Rd Expense Q3 2019 · Sep 30, 2018 $17.43M
Net Income Q3 2019 · Sep 30, 2019 −$4.04M
Net Income Q3 2019 · Sep 30, 2019 −$12.53M
Net Income Q3 2019 · Sep 30, 2018 −$7.25M
Net Income Q3 2019 · Sep 30, 2018 −$24.15M
Operating Income Q3 2019 · Sep 30, 2019 −$4.04M
Operating Income Q3 2019 · Sep 30, 2019 −$12.55M
Operating Income Q3 2019 · Sep 30, 2018 −$7.3M
Operating Income Q3 2019 · Sep 30, 2018 −$24.29M